{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:30:10Z","timestamp":1793694610701,"version":"4.5.1"},"reference-count":218,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373229"],"award-info":[{"award-number":["82373229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472136"],"award-info":[{"award-number":["82472136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503158"],"award-info":[{"award-number":["82503158"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82674007"],"award-info":[{"award-number":["82674007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M782306"],"award-info":[{"award-number":["2025M782306"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.phrs.2026.108462","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:26:39Z","timestamp":1789745199000},"page":"108462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Engineering nanomedicines to reshape tertiary lymphoid structures: A new perspective on antitumor immunotherapy"],"prefix":"10.1016","volume":"233","author":[{"given":"Xueyi","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyi","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9264-6455","authenticated-orcid":false,"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2026.108462_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2021.102597","article-title":"Synthesis of nanomaterials using various top-down and bottom-up approaches, influencing factors, advantages, and disadvantages: a review","volume":"300","author":"Abid","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-025-02305-x","article-title":"Advances in cancer immunotherapy: historical perspectives, current developments, and future directions","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.phrs.2026.108462_bib3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell. & Mol. Immunol."},{"key":"10.1016\/j.phrs.2026.108462_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib5","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.ymthe.2019.07.015","article-title":"Phase I study of lentiviral-transduced chimeric antigen receptor-modified T cells recognizing mesothelin in advanced solid cancers","volume":"27","author":"Haas","year":"2019","journal-title":"Mol. Ther. J. Am. Soc.Gene Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40164-023-00372-8","article-title":"Increasing cure rates of solid tumors by immune checkpoint inhibitors","volume":"12","author":"Ma","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","article-title":"The immune microenvironment of colorectal cancer.","volume":"25","author":"Kennel","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41577-025-01211-z","article-title":"Linking tumour angiogenesis and tumour immunity","volume":"26","author":"Kabir","year":"2026","journal-title":"Nat. Rev. Immunol."},{"issue":"6576","key":"10.1016\/j.phrs.2026.108462_bib9","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40164-025-00695-8","article-title":"In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy","volume":"14","author":"Radandish","year":"2025","journal-title":"Exp. Hematol. & Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J. Hematol. & Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010173","article-title":"Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma","volume":"13","author":"Chung","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2026.108462_bib14","article-title":"Prehabilitation during neoadjuvant chemotherapy results in an enhanced immune response in esophageal adenocarcinoma tumors: A randomized controlled trial","author":"Rayner","year":"2025","journal-title":"J. Sport. Health Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib15","article-title":"An immune cell map of human lung adenocarcinoma development reveals an anti-tumoral role of the Tfh-dependent tertiary lymphoid structure","volume":"5","author":"Liu","year":"2024","journal-title":"Cell. Rep. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","article-title":"Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer","volume":"55","author":"Meylan","year":"2022","journal-title":"Immunity"},{"issue":"7791","key":"10.1016\/j.phrs.2026.108462_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib18","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell."},{"issue":"10","key":"10.1016\/j.phrs.2026.108462_bib19","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/j.immuni.2023.08.009","article-title":"Tertiary lymphoid structures and B cells: An intratumoral immunity cycle","volume":"56","author":"Fridman","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"2","key":"10.1016\/j.phrs.2026.108462_bib21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib22","article-title":"Nanomedicine Reimagined: Translational Strategies for Precision Tumor Theranostics","volume":"38","author":"Wu","year":"2026","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2026.108462_bib23","article-title":"Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives","volume":"7","author":"Frosteg\u00e5rd","year":"2026","journal-title":"Adv. Sci."},{"issue":"Pt 1","key":"10.1016\/j.phrs.2026.108462_bib24","article-title":"pH-responsive carbohydrate polymer-based nanoparticles in cancer therapy","volume":"306","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41571-025-01000-6","article-title":"Enhancing immunotherapy with tumour-responsive nanomaterials","volume":"22","author":"Linderman","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"38","key":"10.1016\/j.phrs.2026.108462_bib26","article-title":"Advances in polymer nanomaterials targeting cGAS-STING pathway for enhanced cancer immunotherapy","volume":"10","author":"Peng","year":"2025","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.10.023","article-title":"Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside","volume":"6","author":"Peyraud","year":"2025","journal-title":"Med"},{"issue":"584","key":"10.1016\/j.phrs.2026.108462_bib28","article-title":"scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20(+) B cells","volume":"1","author":"Ji","year":"2024","journal-title":"Cancer Lett."},{"issue":"613","key":"10.1016\/j.phrs.2026.108462_bib29","article-title":"Tertiary lymphoid structures as a biomarker in immunotherapy and beyond: Advancing towards clinical application","volume":"31","author":"Cui","year":"2025","journal-title":"Cancer Lett."},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1900635","article-title":"Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer","volume":"10","author":"Gunderson","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phrs.2026.108462_bib32","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1158\/1078-0432.CCR-13-2590","article-title":"Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers","volume":"20","author":"Di Caro","year":"2014","journal-title":"Clinical Cancer Res.: An Off. J. Am. Assoc. Cancer Res."},{"issue":"24","key":"10.1016\/j.phrs.2026.108462_bib33","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.3390\/ijms252413286","article-title":"Artificial Tertiary Lymphoid Structures: Exploring Mesenchymal Stromal Cells as a Platform for Immune Niche Formation","volume":"25","author":"Zubkova","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108462_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147480","article-title":"Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry","volume":"14","author":"Le Rochais","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108462_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2016.00407","article-title":"Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention","volume":"7","author":"Saut\u00e8s-Fridman","year":"2016","journal-title":"Front. Immunol."},{"issue":"20","key":"10.1016\/j.phrs.2026.108462_bib36","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"Chaisemartin","year":"2011","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.phrs.2026.108462_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"7787","key":"10.1016\/j.phrs.2026.108462_bib38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","article-title":"An intra-tumoral niche maintains and differentiates stem-like CD8 T cells","volume":"576","author":"Jansen","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib39","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI71611","article-title":"Lymphatic vessels and tertiary lymphoid organs","volume":"124","author":"Ruddle","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2026.108462_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2016.00477","article-title":"Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation","volume":"7","author":"Barone","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108462_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006425","article-title":"Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases. LID","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2026.108462_bib42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3389\/fimmu.2017.00563","article-title":"A Unique Cellular and Molecular Microenvironment Is Present in Tertiary Lymphoid Organs of Patients with Spontaneous Prostate Cancer Regression","volume":"8","author":"Garc\u00eda-Hern\u00e1ndez","year":"2017","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-\u03b2-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib44","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1158\/1078-0432.CCR-15-2762","article-title":"Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer","volume":"22","author":"Kroeger","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib45","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib46","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib47","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1158\/0008-5472.CAN-13-1342","article-title":"Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells","volume":"74","author":"Goc","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2026.108462_bib48","doi-asserted-by":"crossref","first-page":"7114","DOI":"10.1038\/ncomms8114","article-title":"Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity","volume":"6","author":"Peske","year":"2015","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib49","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1084\/jem.20092454","article-title":"Tumor masses support naive T cell infiltration, activation, and differentiation into effectors","volume":"207","author":"Thompson","year":"2010","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib50","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4\u207a follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","article-title":"Regulatory T Cells in Tumor-Associated Tertiary Lymphoid Structures Suppress Anti-tumor T Cell Responses","volume":"43","author":"Joshi","year":"2015","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib52","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s42003-022-04356-y","article-title":"Regulatory T cells infiltrate the tumor-induced tertiary lympho\u00efd structures and are associated with poor clinical outcome in NSCLC","volume":"5","author":"Devi-Marulkar","year":"2022","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005531","article-title":"Maturation and abundance of tertiary lymphoid structures are associated with the efficacy of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer","volume":"10","author":"Sun","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"13","key":"10.1016\/j.phrs.2026.108462_bib54","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1158\/1078-0432.CCR-14-2926","article-title":"Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer","volume":"21","author":"Giraldo","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib55","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/2326-6066.CIR-22-0271","article-title":"A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer Types","volume":"10","author":"Bugatti","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.phrs.2026.108462_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1147480","article-title":"Deciphering the maturation of tertiary lymphoid structures in cancer and inflammatory diseases of the digestive tract using imaging mass cytometry","volume":"14","author":"Le Rochais","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108462_bib57","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fimmu.2016.00477","article-title":"Stromal fibroblasts in tertiary lymphoid structures: a novel target in chronic inflammation","volume":"7","author":"Barone","year":"2016","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.phrs.2026.108462_bib58","doi-asserted-by":"crossref","first-page":"eadk8805","DOI":"10.1126\/sciadv.adk8805","article-title":"Spatiotemporal architecture of immune cells and cancer-associated fibroblasts in high-grade serous ovarian carcinoma","volume":"10","author":"Xu","year":"2024","journal-title":"Sci. Adv."},{"issue":"20","key":"10.1016\/j.phrs.2026.108462_bib59","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1158\/0008-5472.CAN-11-0952","article-title":"Characterization of chemokines and adhesion molecules associated with T cell presence in tertiary lymphoid structures in human lung cancer","volume":"71","author":"de Chaisemartin","year":"2011","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.phrs.2026.108462_bib60","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-11-0431","article-title":"Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer","volume":"71","author":"Martinet","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib61","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.4049\/jimmunol.1300872","article-title":"High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin \u03b2-producing dendritic cells in human breast cancer","volume":"191","author":"Martinet","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/ERC-18-0189","article-title":"Analysis of the immune landscape of small bowel neuroendocrine tumors","volume":"26","author":"Cives","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"issue":"7791","key":"10.1016\/j.phrs.2026.108462_bib63","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib64","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J. Hematol. & Oncol."},{"issue":"10","key":"10.1016\/j.phrs.2026.108462_bib65","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1136\/gutjnl-2022-328697","article-title":"Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas","volume":"72","author":"Kinker","year":"2023","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109422","article-title":"Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts","volume":"36","author":"Rodriguez","year":"2021","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108462_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1439413","article-title":"The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases","volume":"15","author":"Reste","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib68","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.immuni.2017.05.008","article-title":"Lymphatic endothelial cells control initiation of lymph node organogenesis","volume":"47","author":"Onder","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2026.108462_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1231315","article-title":"Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer","volume":"14","author":"Esparcia-Pinedo","year":"2023","journal-title":"Front. Immunol."},{"issue":"588","key":"10.1016\/j.phrs.2026.108462_bib70","article-title":"Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma","volume":"1","author":"Zhang","year":"2023","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib71","first-page":"527","article-title":"High endothelial venules in cancer: Regulation, function, and therapeutic implication","volume":"41","author":"Vella","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib72","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.461","article-title":"Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma","volume":"5","author":"Xu","year":"2024","journal-title":"MedComm"},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006667","article-title":"Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma","volume":"11","author":"Xu","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.phrs.2026.108462_bib74","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejca.2021.03.054","article-title":"CXCL13 shapes tertiary lymphoid structures and promotes response to immunotherapy in bladder cancer","volume":"151","author":"Rouanne","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phrs.2026.108462_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216034","article-title":"PAK4 inhibition improves PD1 blockade immunotherapy in prostate cancer by increasing immune infiltration","volume":"555","author":"Su","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2026.108462_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fimmu.2017.00045","article-title":"High endothelial venules and other blood vessels: critical regulators of lymphoid organ development and function","volume":"8","author":"Ager","year":"2017","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009243","article-title":"Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer","volume":"12","author":"Groen-van Schooten","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2021.12.007","article-title":"TGF-\u03b2-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures","volume":"55","author":"Chaurio","year":"2022","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib79","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.celrep.2016.01.038","article-title":"Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation","volume":"14","author":"Liu","year":"2016","journal-title":"Cell. Rep."},{"key":"10.1016\/j.phrs.2026.108462_bib80","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","article-title":"Follicular helper CD4 T cells (TFH)","volume":"29","author":"Crotty","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib81","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/0008-5472.CAN-24-2274","article-title":"Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy","volume":"85","author":"Ninomiya","year":"2025","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib82","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.immuni.2018.08.025","article-title":"Germinal Center B Cells Replace Their Antigen Receptors in Dark Zones and Fail Light Zone Entry when Immunoglobulin Gene Mutations are Damaging","volume":"49","author":"Stewart","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib83","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","article-title":"Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108462_bib84","article-title":"Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer","volume":"15","author":"Fang","year":"2025","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108462_bib85","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"M., et al, Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2026.108462_bib86","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-024-01980-6","article-title":"Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.489","article-title":"Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.phrs.2026.108462_bib89","article-title":"Tertiary lymphoid structures in cancer: maturation and induction","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2026.108462_bib90","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-026-01814-6","article-title":"Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity","author":"Tang","year":"2026","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.phrs.2026.108462_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101703","article-title":"Activation of B cells in Tertiary Lymphoid Structures in cancer: anti-tumor or anti-self?","volume":"65","author":"Fridman","year":"2023","journal-title":"Semin. Immunol."},{"issue":"7850","key":"10.1016\/j.phrs.2026.108462_bib92","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41586-020-03144-0","article-title":"IgA transcytosis and antigen recognition govern ovarian cancer immunity","volume":"591","author":"Biswas","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib93","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1158\/1078-0432.CCR-16-0081","article-title":"A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases","volume":"23","author":"Montfort","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib94","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41591-022-01821-3","article-title":"Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort","volume":"28","author":"Italiano","year":"2022","journal-title":"Nat. Med."},{"issue":"16","key":"10.1016\/j.phrs.2026.108462_bib95","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/0008-5472.CAN-12-1377","article-title":"Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases","volume":"72","author":"Cipponi","year":"2012","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"25","key":"10.1016\/j.phrs.2026.108462_bib97","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1016\/j.cell.2021.11.007","article-title":"Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses","volume":"184","author":"Cui","year":"2021","journal-title":"Cell"},{"issue":"41","key":"10.1016\/j.phrs.2026.108462_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2221985120","article-title":"Characteristics and anatomic location of PD-1(+)TCF1(+) stem-like CD8 T cells in chronic viral infection and cancer","volume":"120","author":"Im","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib99","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41568-023-00615-0","article-title":"Parish, Ia, Stem-like exhausted and memory CD8(+) T cells in cancer.","volume":"23","author":"Gebhardt","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.immuni.2022.01.018","article-title":"Tfh-cell-derived interleukin 21 sustains effector CD8(+) T cell responses during chronic viral infection","volume":"55","author":"Zander","year":"2022","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib101","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","article-title":"Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T cell differentiation following PD-1 blockade in hepatocellular carcinoma","volume":"29","author":"Magen","year":"2023","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib102","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ccell.2023.04.010","article-title":"Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma","volume":"41","author":"Ramachandran","year":"2023","journal-title":"Cancer Cell."},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib103","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/JLB.5MA0620-039R","article-title":"Anti-CD20 rituximab IgG1, IgG3, and IgG4 but not IgG2 subclass trigger Ca(2+) mobilization and cytotoxicity in human NK cells","volume":"108","author":"Freitas Monteiro","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"23","key":"10.1016\/j.phrs.2026.108462_bib104","article-title":"Tertiary lymphoid structure-associated B cells enhance CXCL13(+)CD103(+)CD8(+)Trm cell response to PD-1 blockade in gastric cancer","author":"Hu","year":"2023","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.phrs.2026.108462_bib105","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1158\/1078-0432.CCR-19-2929","article-title":"Early Hepatic Lesions Display Immature Tertiary Lymphoid Structures and Show Elevated Expression of Immune Inhibitory and Immunosuppressive Molecules","volume":"26","author":"Meylan","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108462_bib106","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12282-018-0910-4","article-title":"Coexistence of regulatory B cells and regulatory T cells in tumor-infiltrating lymphocyte aggregates is a prognostic factor in patients with breast cancer","volume":"26","author":"Ishigami","year":"2019","journal-title":"Breast Cancer"},{"key":"10.1016\/j.phrs.2026.108462_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104819","article-title":"Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE(2)-dependent IgE inhibition in pancreatic cancer","volume":"97","author":"De Monte","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib108","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1880687","article-title":"IgG4 induces tolerogenic M2-like macrophages and correlates with disease progression in colon cancer","volume":"10","author":"Jordakieva","year":"2021","journal-title":"Oncoimmunology"},{"issue":"7680","key":"10.1016\/j.phrs.2026.108462_bib109","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib110","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jdv.18464","article-title":"Features and clinical significance of tertiary lymphoid structure in cutaneous squamous cell carcinoma","volume":"36","author":"Wu","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol. JEADV"},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib111","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/bjc.2015.145","article-title":"Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer","volume":"112","author":"Hiraoka","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib112","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1002\/cam4.5227","article-title":"Peritumor tertiary lymphoid structures are associated with infiltrating neutrophils and inferior prognosis in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib113","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib114","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer immunology immunotherapy CII"},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib115","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/cells12071047","article-title":"Mesenchymal Stem\/Stromal Cells Derived from Cervical Cancer Promote M2 Macrophage Polarization","volume":"12","author":"Cort\u00e9s-Morales","year":"2023","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib116","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/cac2.12486","volume":"43","author":"Qu","year":"2023","journal-title":"Cancer Commun."},{"issue":"2","key":"10.1016\/j.phrs.2026.108462_bib117","doi-asserted-by":"crossref","first-page":"399","DOI":"10.4143\/crt.2016.215","article-title":"Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer","volume":"49","author":"Song","year":"2017","journal-title":"Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib118","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1007\/s00262-022-03310-5","article-title":"Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma","volume":"72","author":"Liu","year":"2023","journal-title":"Cancer immunology immunotherapy CII"},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib119","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3892\/mco.2021.2238","article-title":"Association between the preoperative neutrophil-to-lymphocyte ratio and tertiary lymphoid structures surrounding tumor in gastric cancer","volume":"14","author":"Yamakoshi","year":"2021","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108462_bib120","article-title":"Peritumoral Tertiary Lymphoid Structures Correlate With Protective Immunity and Improved Prognosis in Patients With Hepatocellular Carcinoma","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib121","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/s41416-023-02235-9","article-title":"Density and maturity of peritumoral tertiary lymphoid structures in oesophageal squamous cell carcinoma predicts patient survival and response to immune checkpoint inhibitors","volume":"128","author":"Hayashi","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.phrs.2026.108462_bib122","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41577-019-0269-6","article-title":"Dane, El, Enhancing cancer immunotherapy with nanomedicine.","volume":"20","author":"Irvine","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.phrs.2026.108462_bib123","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jare.2025.06.008","article-title":"Acidic tumor microenvironment-modulated nanoparticle potentiates gastric cancer photoimmunotherapy","volume":"81","author":"Zhu","year":"2026","journal-title":"J. Adv. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib124","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/10717544.2017.1279238","article-title":"pH-Responsive carriers for oral drug delivery: challenges and opportunities of current platforms","volume":"24","author":"Liu","year":"2017","journal-title":"Drug. Deliv."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib125","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/nano10081613","article-title":"pH-Responsive Nanoparticles for Cancer Immunotherapy: A Brief Review. LID","volume":"10","author":"Yan","year":"2020","journal-title":"Nanomaterials"},{"issue":"2","key":"10.1016\/j.phrs.2026.108462_bib126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nbt.1602","article-title":"Rational design of cationic lipids for siRNA delivery","volume":"28","author":"Semple","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"20","key":"10.1016\/j.phrs.2026.108462_bib127","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-13-1117","article-title":"Redox imbalance and biochemical changes in cancer","volume":"73","author":"Jorgenson","year":"2013","journal-title":"Cancer Res."},{"issue":"23","key":"10.1016\/j.phrs.2026.108462_bib128","doi-asserted-by":"crossref","first-page":"23223","DOI":"10.1021\/acsnano.3c06019","article-title":"Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics","volume":"17","author":"Wei","year":"2023","journal-title":"ACS nano"},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib129","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/acs.bioconjchem.1c00492","article-title":"Reduction-Sensitive Dextran-Paclitaxel Polymer-Drug Conjugate: Synthesis, Self-Assembly into Nanoparticles, and In Vitro Anticancer Efficacy","volume":"32","author":"Kanwal","year":"2021","journal-title":"Bioconjugate Chem."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib130","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.phrs.2026.108462_bib131","article-title":"Reactive oxygen species-responsive polymer drug delivery systems","volume":"11","author":"Liu","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib132","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1080\/15548627.2024.2333715","article-title":"MCOLN1\/TRPML1 in the lysosome: a promising target for autophagy modulation in diverse diseases","volume":"20","author":"Qi","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.phrs.2026.108462_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.02.068","article-title":"Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia","volume":"381","author":"Gao","year":"2025","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib134","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40164-025-00622-x","article-title":"Lactylation modification in cancer: mechanisms, functions, and therapeutic strategies","volume":"14","author":"Lv","year":"2025","journal-title":"Exp. Hematol. & Oncol."},{"key":"10.1016\/j.phrs.2026.108462_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100988","article-title":"Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies","volume":"70","author":"Jia","year":"2023","journal-title":"Drug. Resist. Updates"},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib136","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.7150\/thno.14843","article-title":"ATP-responsive and near-infrared-emissive nanocarriers for anticancer drug delivery and real-time imaging","volume":"6","author":"Qian","year":"2016","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib137","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801201","article-title":"Enhancing antitumor efficacy by simultaneous ATP-responsive chemodrug release and cancer cell sensitization based on a smart nanoagent","volume":"5","author":"Song","year":"2018","journal-title":"Adv. Sci."},{"issue":"38","key":"10.1016\/j.phrs.2026.108462_bib138","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1039\/D0CC01213K","article-title":"Reconstruction of nano-flares based on Au-Se bonds for high-fidelity detection of RNA in living cells","volume":"56","author":"Zhan","year":"2020","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib139","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11095-025-03836-0","article-title":"Phytochemicals and their nanoformulations for overcoming drug resistance in head and neck squamous cell carcinoma","volume":"42","author":"Pingping","year":"2025","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.tips.2018.06.003","article-title":"MMP-responsive 'Smart' drug delivery and tumor targeting","volume":"39","author":"Yao","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib141","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12890-020-01317-1","article-title":"Correlation between MMP2 expression in lung cancer tissues and clinical parameters: a retrospective clinical analysis","volume":"20","author":"Han","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib142","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201907210","article-title":"Engineering stimuli-activatable boolean logic prodrug nanoparticles for combination cancer immunotherapy","volume":"32","author":"Hou","year":"2020","journal-title":"Adv. Mater."},{"issue":"19","key":"10.1016\/j.phrs.2026.108462_bib143","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1039\/D3BM00840A","article-title":"MMP-responsive nanomaterials","volume":"11","author":"Son","year":"2023","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib144","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","article-title":"Extracellular matrix and its therapeutic potential for cancer treatment","volume":"6","author":"Huang","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","article-title":"TGF\u03b2 biology in cancer progression and immunotherapy","volume":"18","author":"Derynck","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108462_bib146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2018.03.012","article-title":"Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles","volume":"277","author":"Niu","year":"2018","journal-title":"J. Control. Release"},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib147","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1021\/acs.nanolett.9b03211","article-title":"Transcytosis of nanomedicine for tumor penetration","volume":"19","author":"Liu","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.phrs.2026.108462_bib148","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.jconrel.2020.11.028","article-title":"Cell penetrating peptides: a versatile vector for co-delivery of drug and genes in cancer","volume":"330","author":"Khan","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.108462_bib149","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"\"Combo\" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.phrs.2026.108462_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actbio.2018.12.028","article-title":"Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy","volume":"85","author":"Huang","year":"2019","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib151","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/acs.bioconjchem.7b00808","article-title":"Toll-like Receptor Agonist Conjugation: A Chemical Perspective","volume":"29","author":"Ignacio","year":"2018","journal-title":"Bioconjugate Chem."},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib152","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/acs.bioconjchem.7b00478","article-title":"Pm, bioconjugation approaches to producing subunit vaccines composed of protein or peptide antigens and covalently attached toll-like receptor ligands","volume":"29","author":"Xu","year":"2018","journal-title":"Bioconjugate Chem."},{"issue":"6576","key":"10.1016\/j.phrs.2026.108462_bib153","article-title":"S., S.T.N.a.T.D., Tertiary lymphoid structures in cancer.","volume":"375","year":"2022","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib154","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/nbt.3371","article-title":"vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"7493","key":"10.1016\/j.phrs.2026.108462_bib155","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature12978","article-title":"Structure-based programming of lymph-node targeting in molecular vaccines","volume":"507","author":"Liu","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib156","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.phrs.2026.108462_bib157","article-title":"A novel nanomedicine integrating ferroptosis and photothermal therapy, well-suitable for PD-L1-mediated immune checkpoint blockade","volume":"29","author":"Bao","year":"2024","journal-title":"Mater. Today Bio"},{"issue":"37","key":"10.1016\/j.phrs.2026.108462_bib158","doi-asserted-by":"crossref","first-page":"9963","DOI":"10.1016\/j.biomaterials.2014.08.036","article-title":"Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal\/immune cancer therapy","volume":"35","author":"Tao","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib159","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.apsb.2021.08.012","article-title":"Pure drug nano-assemblies: A facile carrier-free nanoplatform for efficient cancer therapy","volume":"12","author":"Fu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","article-title":"Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response","volume":"24","author":"Jenkins","year":"2025","journal-title":"Mol. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2026.108462_bib161","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.3390\/ijms26146778","article-title":"Tumor microenvironment in melanoma-characteristic and clinical implications","volume":"26","author":"Sikorski","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108462_bib162","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.actbio.2017.11.010","article-title":"Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy","volume":"66","author":"Liu","year":"2018","journal-title":"Acta Biomater."},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib163","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41571-019-0308-z","article-title":"Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges","volume":"17","author":"Martin","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.phrs.2026.108462_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122846","article-title":"Tertiary lymphoid structure formation induced by LIGHT-engineered and photosensitive nanoparticles-decorated bacteria enhances immune response against colorectal cancer","volume":"314","author":"Hu","year":"2025","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib165","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","article-title":"Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy","volume":"40","author":"Asrir","year":"2022","journal-title":"Cancer Cell."},{"key":"10.1016\/j.phrs.2026.108462_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123344","article-title":"Innovative sarcoma therapy using multifaceted nano-PROTAC-induced EZH2 degradation and immunity enhancement","volume":"321","author":"Chen","year":"2025","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.phrs.2026.108462_bib167","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202516348","article-title":"Biodegradable nano-regulator reprograms glioblastoma immunosuppression: pyroptosis-metabolism-immunity crosstalk for cascading immune activation","volume":"65","author":"Qu","year":"2026","journal-title":"Angew. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2026.108462_bib168","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1039\/D3MH00748K","article-title":"Engineering metal-based hydrogel-mediated tertiary lymphoid structure formation via activation of the STING pathway for enhanced immunotherapy","volume":"10","author":"Jin","year":"2023","journal-title":"Mater. Horiz."},{"issue":"2022","key":"10.1016\/j.phrs.2026.108462_bib169","article-title":"Recent advances and next breakthrough in immunotherapy for cancer treatment","volume":"18","author":"Yang","year":"2022","journal-title":"J. Immunol. Res."},{"issue":"45","key":"10.1016\/j.phrs.2026.108462_bib170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409560122","article-title":"Chemokine\/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunity.","volume":"122","author":"Falahat","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib171","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","article-title":"Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib172","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib173","first-page":"9","article-title":"YAP\/TAZ as master regulators in cancer: modulation, function and therapeutic approaches","volume":"4","author":"Piccolo","year":"2023","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib174","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41467-020-14425-7","article-title":"Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors","volume":"11","author":"Huang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2026.108462_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123166","article-title":"Hierarchical protein nano-crystalline hydrogel with extracellular vesicles for ectopic lymphoid structure formation","volume":"318","author":"Ahn","year":"2025","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib176","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.apsb.2024.05.009","article-title":"CCL9\/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-\u03b2","volume":"14","author":"Niu","year":"2024","journal-title":"Acta Pharm. Sin. B."},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib177","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1021\/acsnano.4c01180","article-title":"Biomimetic tertiary lymphoid structures with microporous annealed particle scaffolds for cancer postoperative therapy","volume":"18","author":"Kuang","year":"2024","journal-title":"ACS nano"},{"issue":"48","key":"10.1016\/j.phrs.2026.108462_bib178","article-title":"3D Printing Scaffold Vaccine for Antitumor Immunity","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.phrs.2026.108462_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123976","article-title":"Self-assembled microparticle hydrogel scaffolds to construct artificial tertiary lymphoids for enhanced CAR-T cell therapy against solid tumors","volume":"329","author":"Li","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2026.108462_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113897","article-title":"Injectable hydrogel-based drug formulation for enhancing tertiary lymphoid structure formation and cancer immunotherapy efficacy","volume":"384","author":"Kuwentrai","year":"2025","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.phrs.2026.108462_bib181","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41577-019-0257-x","article-title":"B cells, plasma cells and antibody repertoires in the tumour microenvironment","volume":"20","author":"Sharonov","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib182","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"13","key":"10.1016\/j.phrs.2026.108462_bib183","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1021\/acsnano.3c13038","article-title":"Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B\/CD 4 T Cell Crosstalk","volume":"18","author":"Li","year":"2024","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib184","first-page":"132","article-title":"Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade","volume":"41","author":"Bai","year":"2022","journal-title":"Journal experimental & clinical cancer research CR"},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib185","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol. Cell."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib186","doi-asserted-by":"crossref","first-page":"eadr1299","DOI":"10.1126\/sciadv.adr1299","article-title":"Intratumoral antigen-presenting cell activation by a nanovesicle for the concurrent tertiary lymphoid structure de novo neogenesis","volume":"11","author":"Cheng","year":"2025","journal-title":"Sci. Adv."},{"issue":"23","key":"10.1016\/j.phrs.2026.108462_bib187","doi-asserted-by":"crossref","first-page":"21385","DOI":"10.1021\/acsnano.5c01280","article-title":"Cognate nanovaccine promotes tertiary lymphoid structures function and strengthens immune cell cross-talk by targeting exhausted t cells in nonimmunogenic cancers","volume":"19","author":"Chen","year":"2025","journal-title":"ACS nano"},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib188","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1021\/acsnano.2c09619","article-title":"Nanovaccines fostering tertiary lymphoid structure to attack mimicry nasopharyngeal carcinoma","volume":"17","author":"Wen","year":"2023","journal-title":"ACS nano"},{"key":"10.1016\/j.phrs.2026.108462_bib189","first-page":"283","article-title":"Engineered bacterial membrane biomimetic covalent organic framework as nano-immunopotentiator for cancer immunotherapy","volume":"47","author":"Yang","year":"2025","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib190","first-page":"84","article-title":"Multiple mechanisms and applications of tertiary lymphoid structures and immune checkpoint blockade","volume":"44","author":"Li","year":"2025","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib191","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment's role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.phrs.2026.108462_bib192","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2025.12.011","article-title":"B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity","volume":"44","author":"Chen","year":"2026","journal-title":"Cancer Cell."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib193","doi-asserted-by":"crossref","first-page":"9033","DOI":"10.1038\/s41467-024-53262-w","article-title":"Spatial dynamics of CD39(+)CD8(+) exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer","volume":"15","author":"Tanoue","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib194","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.apsb.2024.05.009","article-title":"CCL9\/CCR1 axis-driven chemotactic nanovesicles for attenuating metastasis of SMAD4-deficient colorectal cancer by trapping TGF-\u03b2","volume":"14","author":"Niu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib195","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ccell.2025.03.019","article-title":"CAR-T therapy in solid tumors","volume":"43","author":"Du","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.phrs.2026.108462_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217350","article-title":"Frontiers in pancreatic cancer on biomarkers, microenvironment, and immunotherapy","volume":"610","author":"Yu","year":"2025","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib197","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41590-020-0635-3","article-title":"Lymph node stromal cells: cartographers of the immune system.","volume":"21","author":"Krishnamurty","year":"2020","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib198","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-026-02608-5","article-title":"Chemo-photothermal synergy ignites antitumor immunity via ferroptosis. LID","volume":"11","author":"Lin","year":"2026","journal-title":"LID - 98. Signal. Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.phrs.2026.108462_bib199","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2017.e00407","article-title":"Lambda phage-based vaccine induces antitumor immunity in hepatocellular carcinoma","volume":"3","author":"Iwagami","year":"2017","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/ijms23010402","article-title":"Bacteriophages as Solid Tumor Theragnostic Agents. LID","volume":"23","author":"Veeranarayanan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib201","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1084\/jem.20180344","article-title":"The conduit system exports locally secreted IgM from lymph nodes","volume":"215","author":"Thierry","year":"2018","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108462_bib202","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41578-019-0110-7","article-title":"Material design for lymph node drug delivery","volume":"4","author":"Schudel","year":"2019","journal-title":"Nat. Rev.Materials"},{"issue":"12","key":"10.1016\/j.phrs.2026.108462_bib203","doi-asserted-by":"crossref","first-page":"19691","DOI":"10.1021\/acsnano.2c07286","article-title":"Recent Progress and Trends in X-ray-Induced Photodynamic Therapy with Low Radiation Doses.","volume":"16","author":"He","year":"2022","journal-title":"ACS nano"},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib204","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41467-024-55430-4","article-title":"Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib206","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.phrs.2026.108462_bib207","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.it.2020.06.010","article-title":"Organoid Models of Tumor Immunology","volume":"41","author":"Yuki","year":"2020","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108462_bib208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/cells13040363","article-title":"Vitro Glioblastoma Model on a Plate for Localized Drug Release Study from a 3D-Printed Drug-Eluted Hydrogel Mesh","volume":"13","author":"Chehri","year":"2024","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.phrs.2026.108462_bib209","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708662","article-title":"Innovations, challenges, and minimal information for standardization of humanized mice","volume":"12","author":"Stripecke","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"11","key":"10.1016\/j.phrs.2026.108462_bib210","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/2159-8290.CD-18-0044","article-title":"Mouse models for cancer immunotherapy research","volume":"8","author":"Olson","year":"2018","journal-title":"Cancer Discov."},{"issue":"20","key":"10.1016\/j.phrs.2026.108462_bib211","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201800391","article-title":"\"Smart\" nanoprobes for visualization of tumor microenvironments","volume":"7","author":"Ma","year":"2018","journal-title":"Adv. Healthc. Mater."},{"issue":"Pt A","key":"10.1016\/j.phrs.2026.108462_bib212","article-title":"Advances in the near-infrared \u2161 for in vivo fluorescence imaging applications: a review","volume":"297","author":"Zou","year":"2026","journal-title":"Talanta"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib213","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13058-024-01844-3","article-title":"Evaluating the immunologically \"cold\" tumor microenvironment after treatment with immune checkpoint inhibitors utilizing PET imaging of CD4\u2009+\u2009and CD8\u2009+\u2009T cells in breast cancer mouse models","volume":"26","author":"Lu","year":"2024","journal-title":"Breast cancer research BCR"},{"key":"10.1016\/j.phrs.2026.108462_bib214","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jconrel.2022.10.004","article-title":"Nanomedicine for advanced cancer immunotherapy","volume":"351","author":"Diep","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2026.108462_bib215","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218098","article-title":"Design of nano-delivery systems for pancreatic cancer immunotherapy","volume":"635","author":"Fu","year":"2025","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.phrs.2026.108462_bib216","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1039\/C4CS00011K","article-title":"Near-infrared light-responsive nanomaterials in cancer therapeutics","volume":"43","author":"Shanmugam","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.phrs.2026.108462_bib217","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications","volume":"200","author":"Wicki","year":"2015","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.phrs.2026.108462_bib218","doi-asserted-by":"crossref","DOI":"10.1111\/imr.70062","article-title":"From lymphotoxin to tertiary lymphoid structures and beyond","volume":"335","author":"Ruddle","year":"2025","journal-title":"Immunol. Rev."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826003774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:15:31Z","timestamp":1793693731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826003774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":218,"alternative-id":["S1043661826003774"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108462","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering nanomedicines to reshape tertiary lymphoid structures: A new perspective on antitumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108462"}}